The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice

Cancer Research

Volumn 63, Issue 9, 2003, Pages 2005-2009

  Brembeck, Felix H ^a,b   Schreiber, Franz S ^a,b   Deramaudt, Therese B ^a,b   Craig, Linden ^c   Rhoades, Ben ^a,b   Swain, Gary ^a   Grippo, Paul ^d   Stoffers, Doris A ^a   Silberg, Debra G ^a   Rustgi, Anil K ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKERATIN 19; NERVE CELL ADHESION MOLECULE; PROTEIN P16; PROTEIN P53; SMAD4 PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL HYPERPLASIA; CELL MIGRATION; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; ONCOGENE K RAS; PANCREAS CARCINOMA; PANCREAS DUCT; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOUTHERN BLOTTING; STEM CELL; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; STOMACH EPITHELIUM; STOMACH MUCOSA; T LYMPHOCYTE; TRANSGENIC MOUSE; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL TRANSFORMATION, NEOPLASTIC; GASTRIC MUCOSA; GENES, RAS; HUMANS; HYPERPLASIA; KERATINS; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, TRANSGENIC; MUTATION; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0038743167     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53: 549-554, 1988.
2. Smit, V. T., Boot, A. J., Smits, A. M., Fleuren, G. J., Cornelisse, C. J., and Bos, J. L. K-ras codon 12 mutations occur very frequently in pancreatic adenocareinomas. Nucleic Acids Res., 16: 7773-7782, 1988.
3. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTSI) gene in pancreatic adenocarcinoma. Nat. Genet., 8: 27-32, 1994.
4. Redston, M. S., Caldas, C., Seymour, A. B., Hruban, R. H., da Costa, L., Yeo, C. J., and Kern, S. E. P53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res., 54: 3025-3033, 1994.
5. Rozenblum, E., Schutte, M., Goggins, M., Hahn, S. A., Panzer, S., Zahurak, M., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., and Kem, S. E. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res., 57: 1731-1734, 1997.
6. Ruggeri, B., Zhang, S. Y., Caamano, J., DiRado, M., Flynn, S. D., Klein-Szanto, A. J. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppossor genes. Oncogene, 7: 1503-1511, 1992.
7. Scarpa, A., Capelli, P., Mukai, K., Zamboni, G., Oda, T., Iacono, C., and Hirohashi, S. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am. J. Pathol., 142: 1534-1543, 1993.
8. Quaife, C. J., Pinkert, C. A., Ornitz, D. M., Palmiter, R. D., and Brinster, R. L. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell, 48: 1023-1034, 1987.
9. Brembeck, F., and Rustgi, A. K. The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Spl. J. Biol. Chem., 275: 28230-28239, 2000.
10. Brembeck, F., Moffett, J., Wang, T. C., and Rustgi, A. K. The keratin 19 promoter is potent for cell-specific targeting of genes in transgenic mice. Gastroenterology, 120: 1720-1728, 2001.
11. Yip-Schneider, M. T., Lin, A., Barnard, D., Sweeney, C. J., and Marshall, M. S. Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas in oncogenic K-ras expression. Int. J. Oncol., 15: 271-279, 1999.
12. Hruban, R. H., et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am. J. Surg. Pathol., 25: 579-586, 2001.
13. Abrams, S. I., Stanziale, S. F., Lunin, S. D., Zaremba, S., and Schlom, J. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses. Eur. J. Immunol., 26: 435-443, 1996.
14. Tanaka, Y., Ohyama, H., Ogawa, M., Nishimura, Y., and Matsushita, S. H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cells. J. Immunol., 163: 6209-6216, 1999.
15. Johnson, P. W., Trimble, W. S., Hozumi, N., and Roder, J. C. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells. J. Immunol., 138: 3996-4003, 1987.
16. Kostetskii, I., Moore, R., Kemler, R., and Radice, G. L. Differential adhesion leads to segregation and exclusion of N-cadherin-deficient cells in chimeric embryos. Dev. Biol., 234: 72-79, 2001.
17. Esni, F., Johansson, B. R., Radice, G. L., and Semb, H. Dorsal pancreas agenesis in N-cadherin-deficient mice. Dev. Biol., 238: 202-212, 2001.
18. Hermiston, M. L., and Gordon, J. I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science (Wash. DC), 270: 1203-1206, 1995.
19. Wagner, M., Luhrs, H., Kloppel, G., Adler, G., and Schmid, R. M. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology, 115: 1254-1262, 1998.
20. Greten, F. R., Wagner, M., Weber, C. K., Zechner, U., Adler, G., and Schmid, R. M. TGF alpha transgenic mice. A model of pancreatic cancer development. Pancreatology, 1: 363-368, 2001.
21. Wagner, M., Greten, F. R., Weber, C. K., Koschnick, S., Mattfeldt, T., Deppert, W., Kern, H., Adler, G., and Schmid, R. M. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev., 15: 286-293, 2001.
22. Bardeesy, N., Morgan, J., Sinha, M., Signoretti, S., Srivastava, S., Loda, M., Merlino, G., and DePinho, R. A. Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia. Mol. Cell. Biol., 22: 635-643, 2002.
23. Li, Q., Karam, S. M., and Gordon, J. I. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J. Biol. Chem., 271: 3671-3676, 1996.
24. Karam, S. M., and Gordon, J. I. Gastric epithelial morphogenesis in normal and transgenic mice. Am. J. Physiol., 272: G1209-G1220, 1997.
25. El-Rifai, W., and Powell, S. M. Molecular biology of gastric cancer. Semin. Radiat. Oncol., 12: 128-140, 2002.